Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma

Cancer. 1984 Jul 15;54(2):315-8. doi: 10.1002/1097-0142(19840715)54:2<315::aid-cncr2820540223>3.0.co;2-6.

Abstract

Liver tissues of 223 autopsy cases of cirrhosis and hepatocellular carcinoma were examined for liver cell dysplasia in relation to hepatitis B surface antigen (HBsAg) detected with orcein stain. Liver cell dysplasia was found in 94 cases (42.2%): 37 were from cases of cirrhosis only, and 53 were from cases of cirrhosis with hepatocellular carcinoma. There was a significant difference in the overall incidence of HBsAg in cases with and without dysplasia (70.2%:32.6%). A similar difference was found in all groups, i.e., those with cirrhosis, cirrhosis with hepatocellular carcinoma, and hepatocellular carcinoma only, in which none of 11 cases of HBsAg negative had dysplasia. A good correlation was seen between the semiquantitative grade of dysplasia and the incidence of HBsAg. These findings suggest a close relationship of HBsAg with liver cell dysplasia.

MeSH terms

  • Autopsy
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / immunology
  • Carcinoma, Hepatocellular / pathology*
  • Cell Nucleus / pathology
  • Female
  • Hepatitis B Surface Antigens / analysis*
  • Histocytochemistry
  • Humans
  • Liver / pathology*
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / immunology
  • Liver Cirrhosis / pathology*
  • Liver Neoplasms / complications
  • Liver Neoplasms / immunology
  • Liver Neoplasms / pathology*
  • Male
  • Middle Aged
  • Staining and Labeling

Substances

  • Hepatitis B Surface Antigens